Francisco Diaz- Mitoma

Company: VBI Vaccines

Job title: Chief Medical Officer

Seminars:

Panel Discussion: Defining Clinical Endpoints & Exploring Surrogates for HBV Functional Cure 8:30 am

• Reflecting cccDNA activity and assessing durability of hepatitis B surface antigen seroclearance • Outlining parameters for acceptable and clinically meaningful hepatitis B surface antigen loss and opportunities to implement alternative surrogate endpoints • Future directions: looking towards a sterilizing cureRead more

day: Day Two